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In The World Is Flat and his other
landmark books on globalization, journal-
ist, columnist, and author Thomas Fried-
man eloquently articulates the prospect of
a new world order and economy as a
consequence of emerging new technolo-
gies, business practices, and world events
[1]. Heading the list of ‘‘flatteners’’ that
have leveled the new economic world are
Netscape and the Web, common software
platforms from Microsoft and elsewhere,
search engines, open access and open
sourcing, outsourcing, offshoring, supply
chaining and insourcing, and mobile
phones and other personal digital devices
[1]. At the same time, globalization has
also emerged as an important force in
revealing the devastating health and
economic impact of disease on human
populations worldwide [2]. Through open
access, PLoS Neglected Tropical Diseases is
helping to increase awareness of the
neglected tropical diseases (NTDs) as the
most common infections of the ‘‘bottom
billion,’’ i.e., the world’s poorest people
living on less than US$1 per day in
developing countries [3]. By causing
adverse effects on child development and
learning, pregnancy outcome, and agri-
cultural productivity, the NTDs are
emerging as one of the most important
group of infections that trap the poorest
people living in sub-Saharan Africa, Asia,
and the Americas in a cycle of poverty and
destitution [2,3]. The NTDs both occur in
the setting of poverty and promote poverty
[3].
New studies published in 2008 have also
shown that in our newly flattened world
the NTDs do not occur exclusively in
developing countries [4]. Instead, wherev-
er poverty is pervasive, even in otherwise
wealthy countries such as the United
States, some important parasitic and other
infections are endemic, and they cause
significant adverse effects on maternal and
child health [4]. Shown in Table 1 is a
comparison of some of these neglected
diseases occurring in underrepresented
minority African American and Hispanic
populations in the US with populations
living in Nigeria and Mexico, respectively.
For example, the parasitic disease tricho-
moniasis is one of the most common
infections adversely affecting reproductive
health among African American women.
Among this population in the US, the
national prevalence of Trichomonas vaginalis
infection was recently estimated at 13%
[5], but it has been found to be as high as
29% among African American women
attending a clinic for sexually transmitted
diseases in Baltimore [6]. By comparison,
in Ogun State, Nigeria, 38% of women
attending a fertility clinic were found to be
infected with T. vaginalis [7]. Similarly, the
prevalence rate of toxocariasis, a parasitic
worm infection linked to asthma and
epilepsy, was recently estimated among
African Americans nationally at 21% [8],
compared with a prevalence of 30% in
Plateau State, Nigeria [9].
Nearly 600,000 African Americans are
living with HIV/AIDS and as many as
30,000 become infected each year [10]. In
their August 2008 report, Left Behind: Black
America: A Neglected Priority in the Global AIDS
Epidemic, the Black AIDS Institute makes
the poignant comment that if Black
America was a country, its economy would
be almost as large as that of South Africa,
and that ‘‘a free-standing Black America
would rank 16th in the world in the
number of people living with HIV’’ [10].
They further state that in US inner cities
and the American South the prevalence of
HIV/AIDS approaches those reported in
some of the most heavily affected countries
in Africa [10]. Indeed, the prevalence of
HIV/AIDS in Nigeria is only slightly
greater than that in Black America
[10,11].
Cysticercosis, dengue, and Chagas dis-
ease are now endemic in the US among
impoverished Hispanic populations, and
in some cases the rates of these NTDs are
comparable to those in poor regions of
Latin America [4,12–14]. Some of these
cases in the US have emerged because of
globalization and international migration
[15,16], but there is also strong evidence
now for transmission of these parasitic
diseases within US borders [4,16–19]. The
common denominator for neglected infec-
tions in the US such as trichomoniasis,
toxocariasis, HIV/AIDS, cysticercosis,
and Chagas disease, is poverty, not
immigration [4]. Among Native Ameri-
cans in the US, although invasive Hae-
mophilus influenzae type b (Hib) infection is
no longer common because of adequate
vaccination coverage against this infection,
invasive H. influenzae type a infection now
occurs [20], and in some cases at rates that
can be compared with Hib rates among
unvaccinated populations in Africa [21].
The similarities between NTDs and
HIV/AIDS in the US and in developing
countries illustrate an interesting feature
about Friedman’s flat world. Just as
aspiring nations such as India and China
exploit new technologies that level their
playing field with the US and Europe, the
same playing field is (sadly) also being
leveled on the other side. Even in wealthy
countries such as the US, there are intense
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tions can and do occur. As I pointed out
previously, no one would argue that
American poverty is nearly as pervasive
or as intense as it is in sub-Saharan Africa
or even in the poorest regions of Latin
America or Asia [22], but it is nonetheless
sufficiently severe among the estimated 36
million people living below the poverty
line in the US for many poor Americans to
be at risk for some important NTDs
[4,22]. It would also be worth exploring
NTD rates in other parts of the developed
world, such as those for leishmaniasis and
other neglected infections in Europe
[23,24], intestinal helminth infections and
ectoparasitic infections among aboriginal
populations in Australia [25,26], and
anisakiasis, echinococcosis, strongyloidia-
sis, toxocariasis, and other parasitic and
vector-borne NTDs in Japan [27–32]. An
emerging global financial crisis in 2008
and 2009 is not likely to help this situation
and could exacerbate even further infec-
tious disease health disparities everywhere.
The rates of non-communicable chronic
diseases such as cancer and cardiovascular
diseases would also be worth comparing
between developed and developing coun-
tries.
Because NTDs are still largely forgotten
diseases among forgotten people, we are at
an early stage of having detailed informa-
tion about their actual prevalence or
incidence in both developing and devel-
oped countries. Accordingly, PLoS Neglected
Tropical Diseases continues to solicit and
review papers that measure disease bur-
dens wherever poor people live [33]. In
the meantime, awareness of the NTDs and
their health and socioeconomic impor-
tance continues to increase among policy-
makers in the global public health com-
munity, while simultaneously funds are
slowly increasing in order to provide
support for access to essential medicines
for NTDs among the world’s poorest
people. Given their importance in pro-
moting poverty and the low-cost options
now available for controlling or eliminat-
ing NTDs [2,3], taking on these conditions
may represent one of the most effective
and cost-efficient solutions for addressing
the Millennium Development Goals
[2,3,34]. At the same time, it will be
important to consider that in our flattened
world it will be easy if not convenient to
forget about NTDs in the US, Europe,
Australia, and Japan. Our approach
should include both addressing the social
structures in which neglected infections
flourish as well as research and develop-
ment for new diagnostics, drugs, and
vaccines. It will be a challenge to not
leave the poor stranded among the
wealthy, but in the world order outlined
by Friedman, if the wealthiest countries
wish to remain global competitors, indi-
viduals and societies in the lowest socio-
economic groups affected by neglected
diseases (in any nation of the world,
including the US) must be provided access
to medicines and innovations for these
conditions. This is also a fundamental
issue in human rights [35] that we cannot
ignore.
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